Oral Cancer: Page 21

HELPTAG:PO_Vaccine_To_Help_Prevent_Oral_Cancer

February 1, 2016

NYU, UCLA get $2.4M grant to study cannabinoids for cancer pain

By DrBicuspid.com staff writers

The New York University (NYU) Bluestone Center for Clinical Research and the University of California, Los Angeles (UCLA) have received a five-year, $2.4 million grant from the National Cancer Institute to study the use of nonpsychotropic cannabinoids to suppress chronic cancer pain.

January 28, 2016

NCI cancer centers call for more HPV vaccinations

By DrBicuspid.com staff writers

All 69 of the National Cancer Institute (NCI)-designated cancer centers issued a statement calling for an increase in the number of HPV vaccinations.

January 26, 2016

DrBicuspid.com announces the 2015 Dental Excellence Award winners

By Tony Edwards

DrBicuspid.com is pleased to announce the winners of the 2015 Dental Excellence Awards. Awards will be handed out at the Chicago Dental Society Midwinter Meeting in February.

January 25, 2016

Global Oral Cancer forum to take place in March

By DrBicuspid.com staff writers

The inaugural Global Oral Cancer Forum will be held on March 4 and 5 at New York University in New York City.

January 24, 2016

U-M study finds natural dairy preservative kills cancer cells

By DrBicuspid.com staff writers

University of Michigan (U-M) researchers have found that nisin, a naturally occurring preservative that grows on dairy products, killed between 70% and 80% of head and neck cancer tumor cells in rodents after nine weeks and extended survival in a new study, according to a university release.

January 21, 2016

Study: Data suggest novel approach to treat early-stage oral cancer

By Tony Edwards

Of the many ongoing issues around oral cancer treatment is a lack of "significant improvement" in disease prognosis over the last several decades. Now a study in JAMA Otolaryngology -- Head and Neck Surgery presents, for the first time, outcome data for almost 250 patients using a novel optical approach at the point of care to treat early-stage oral cancer.

January 19, 2016

FDA fast-tracks Galera's oral mucositis therapy

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) has granted fast-track status to Galera Therapeutics for a drug that may reduce the severity and incidence of radiation- and chemotherapy-induced oral mucositis.

January 11, 2016

FDA OKs nonalcohol docetaxel for head/neck cancer

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) has approved Teikoku Pharma USA's nonalcohol docetaxel injection for the treatment of head and neck cancer, breast cancer, non-small cell lung cancer, prostate cancer, and gastric adenocarcinoma.

December 28, 2015

Study: PET/CT aids radiation treatment in HNC patients

By Donna Domino

The use of PET/CT can improve radiation treatment planning for patients with head and neck cancers (HNCs), according to a review of studies that was recently published in the World Journal of Radiology.

December 28, 2015

Forward Science donates 5th OralID

By DrBicuspid.com staff writers

Forward Science Technologies, the developer of the OralID cancer screening device, has donated a fifth device as part of its OralID Facebook Charity Campaign.

December 21, 2015

Bavarian Nordic partners with Janssen for HPV vaccine

By DrBicuspid.com staff writers

Bavarian Nordic has entered into a license and collaboration agreement with Janssen Pharmaceuticals to target HPV-related cancers.

December 20, 2015

Previous Page

Page 21 of 117

Next Page